Skip to main content

Table 2 Clinical predictors for weight loss before treatment

From: Impact of weight loss on survival after chemoradiation for locally advanced head and neck Cancer: secondary results of a randomized phase III trial (SAKK 10/94)

Weight loss before treatment

 

No weight loss

<=5% weight loss

>5-10% weight loss

>10% weight loss

p-value*

Sex = Female

15 (46.9%)

4 (12.5%)

11 (34.4%)

2 (6.2%)

0.09

Sex = Male

63 (37.7%)

45 (26.9%)

34 (20.4%)

25 (15.0%)

 

WHO performance = 0

51 (44.3%)

33 (28.7%)

23 (20.0%)

8 (7.0%)

0.004

WHO performance > = 1

27 (32.1%)

16 (19.0%)

22 (26.2%)

19 (22.6%)

 

Age < 50 years

21 (38.2%)

14 (25.5%)

6 (10.9%)

14 (25.5%)

0.006

Age > = 50 years

57 (39.6%)

35 (24.3%)

39 (27.1%)

13 (9.0%)

 

Site = Hypopharynx

21 (42.9%)

10 (20.4%)

16 (32.7%)

2 (4.1%)

0.04

Site = Other

57 (38.0%)

39 (26.0%)

29 (19.3%)

25 (16.7%)

 

T classification = cT1-2

21 (52.5%)

9 (22.5%)

9 (22.5%)

1 (2.5%)

0.06

T classification = cT3-4

57 (35.8%)

40 (25.2%)

36 (22.6%)

26 (16.4%)

 

N classification = cN0-1

41 (50.0%)

18 (22.0%)

15 (18.3%)

8 (9.8%)

0.07

N classification = cN2-3

37 (31.6%)

31 (26.5%)

30 (25.6%)

19 (16.2%)

 

Parenteral nutrition or feeding tube = No

48 (39.0%)

35 (28.5%)

22 (17.9%)

18 (14.6%)

0.2

Parenteral nutrition or feeding tube = Yes

30 (40.5%)

14 (18.9%)

22 (29.7%)

8 (10.8%)

 

Hemoglobin > = 14 g/dL

52 (48.1%)

30 (27.8%)

21 (19.4%)

5 (4.6%)

<0.001

Hemoglobin < 14 g/dL

26 (28.6%)

19 (20.9%)

24 (26.4%)

22 (24.2%)

 
  1. *Fisher‘s Exact test.